Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Cancer Genetics, Inc.

NASDAQ: CGIXHealthcare / Medical Laboratories & Research / USA
0.3100+0.0500+19.23%Vol 5 371 4551Y Perf -84.49%
Jan 17th, 2019 16:00
BID0.3100 ASK0.3100
Open0.2800 Previous Close0.2600
Pre-Market0.29 After-Trading-
 0.03 11.54%  - -%
Target Price
4.50 
Analyst Rating
Moderate Buy 2.00
Potencial %
1 351.61 
Finscreener Ranking
     40.84
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
     31.44
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
     32.41
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)9 
Earnings Rating
Buy
Price Range Ratio 52wk %
5.50 
Earnings Date
22nd Nov 2018

Today's Price Range

0.28000.3200

 

52wk Range

0.20002.20

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
19.23%
3 Months
-63.95%
6 Months
-65.17%
1 Year
-84.49%
3 Years
-86.16%
5 Years
-98.05%

Quotes

Name / TickerPriceChg.Chg.%
CGIX0.31000.050019.23
AAPL155.860.92000.59
GOOG1 089.908.93000.83
MSFT106.120.74000.70
XOM72.130.49000.68
WFC49.230.29000.59
JNJ129.091.05000.82
FB148.300.76000.52
GE9.140.16001.78
JPM102.920.42000.41
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
0.40
Current Ratio
0.50
Long Term Debt to Total Capital
0.05
Total Debt to Equity
1.28
Interest Coverage
-8.80
Leverage Ratio 2.70
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
29.60
EBIT Margin
-81.70
EBITDA Margin
-74.00
Pre-tax Profit Margin
-104.20
Profit Margin
-80.45
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
0.80
PS Ratios
0.36
Price to Cash Flow
-
Price to Free Cash Flow
-0.70
Cash Flow Per Share
-0.57
Price to Tangible Book
-0.61
Book Value per Share
0.33
Enterprise Value (in ths.)
18 052
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-61.32
ROE last 12 Months
-121.38
Return on Assets (5Y Avg)
-36.60
ROA last 12 Months
-52.23
Return on Capital (5Y Avg)
-47.81
ROC last 12 Months
-73.32
Return on invested Capital Q
-33.16
Return on invested Capital Y
-55.43
Assets Turnover
0.20
Receivables Turnover
0.70
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
20 643
Revenue per Share
0.74
Revenue Growth 3 Years
7.86
Revenue Growth 5 Years
32.26
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.16-0.23-43.75
Q02 2018-0.13-0.130.00
Q01 2018--0.16-
Q04 2017--0.35-
Q03 2017-0.13-0.16-23.08
Q02 2017-0.16-0.160.00
Q01 2017-0.18-0.1138.89
Q04 2016-0.22-0.1531.82
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.130.00-
12/2018 FY-0.580.00-
3/2019 QR-0.070.00-
12/2019 FY-0.110.00-
Next Report Date-
Estimated EPS Next Report-0.16
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume5 371 455
Shares Outstanding (in ths.)27 750
Trades Count5 524
Dollar Volume1 566 582
Avg. Volume2 704 218
Avg. Weekly Volume2 835 523
Avg. Monthly Volume2 119 426
Avg. Quarterly Volume1 081 631

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

30%70%

Bearish Bullish

47%53%

Bearish Bullish

70%30%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (50.00 %)
2 (50.00 %)
2 (50.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (50.00 %)
2 (50.00 %)
2 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.00
Moderate Buy
2.00
Moderate Buy
2.00

There are no comments yet.

News